- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04563910
Impact of Duration of Untreated Manic Episodes on Clinical Outcome
Impact of Duration of Untreated Bipolar Disorder (Manic Episodes) on Clinical Outcome
Study Overview
Status
Intervention / Treatment
Detailed Description
Mood disorder carries a major burden in our country as it represents 15% of inpatients and 20% of outpatients in mental hospitals in Egypt
The current work is designed to study the effect of duration of untreated bipolar disorder on clinical outcome ( severity , residual symptoms ,duration of hospital admission) and to study factors affecting duration of untreatment in Upper Egypt.
The current study is cross sectional retrospective study, included 100 patients were diagnosed as mood disorder bipolar I (manic episodes) according to DSM5, patients recruited from inpatient psychiatric unit at department of Neurology and Psychiatry, Assiut University hospitals
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt
- Assiut University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- -Age group between 18 to 45 years old.
- Patients diagnosed as mood disorder bipolar I manic episode according to DSM V(2).
- Clearly consenting to participate in the study.
Exclusion Criteria:
- -Mood disorder due to substance abuse.
- Patients in depressive episodes.
- other mental disorders
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
less than 2 episodes
Patients were classified into 3 groups according to number of episodes (1-2 episodes, 3-5 episodes, more than 5 episodes)
|
questionnaires to the patients and their family after their written consent
Other Names:
|
2-5 episodes
Patients were classified into 3 groups according to number of episodes (1-2 episodes, 3-5 episodes, more than 5 episodes)
|
questionnaires to the patients and their family after their written consent
Other Names:
|
more than 5 episodes
Patients were classified into 3 groups according to number of episodes (1-2 episodes, 3-5 episodes, more than 5 episodes)
|
questionnaires to the patients and their family after their written consent
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
measure the effect of duration of untreated bipolar disorder on severity (young mania rating scale on admission
Time Frame: one year
|
To study the effect of duration of untreated bipolar disorder (manic episodes) on clinical outcomes (severity).
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To measure the effect of duration of untreated bipolar disorder (manic episodes) on clinical outcomes (severity, residual symptoms, duration of admission).
Time Frame: one year
|
residual symptoms measured by young mania rating scale on discharge
|
one year
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17101199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Diagnosed With Bipolar Disorder ( Manic Episodes) and Delayed Diagnosis
-
Memory PharmaceuticalsStanley Medical Research InstituteCompletedSafety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I DisorderBipolar Disorder With Manic or Mixed EpisodesUnited States
-
AstraZenecaCompletedAcute Bipolar Manic EpisodeCroatia, Italy, Turkey, United Kingdom, Germany, Belgium, Finland, Denmark
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompletedBipolar I Disorder | Manic EpisodeUnited States, Croatia, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompletedBipolar I Disorder | Manic EpisodeSerbia, United States, Bulgaria, Poland
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Dongbin LyuRecruiting
-
Mayo ClinicRecruiting
-
Bial - Portela C S.A.Completed
Clinical Trials on young mania rating scale
-
CHU de ReimsUnknownBipolar Disorder, SchizophreniaFrance
-
Rambam Health Care CampusUnknownStress Disorders, Post-Traumatic | Depressive Disorder, MajorIsrael
-
Istanbul Medipol University HospitalCompletedPain | Dental PainTurkey
-
Jessa HospitalCompletedScar | Minimally Invasive Cardiac SurgeryBelgium
-
University Hospital, RouenCompletedPain | Cystic FibrosisFrance
-
University GhentEnrolling by invitation
-
University of South FloridaCompletedFriedreich's Ataxia | Spinocerebellar Ataxia - All Sub-typesUnited States
-
Fondazione NeurecaUnknownParkinson's DiseaseItaly
-
Delta University for Science and TechnologyCompletedAttention Deficit DisorderEgypt
-
Assiut UniversityCompleted